NuCana Q3 2024 Earnings SmallerthanExpected Loss as Biotech Advances Oncology Pipeline GLDD Q4 2025 Earnings Strong Earnings Beat Amid Operational Improvements CMCT Q3 2024 Earnings Massive EPS Miss Rattles Investor Confidence ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline NTRSO Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment GIB Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher